TD Cowen Downgrades Immuneering Corporation (IMRX) to Market Perform Mar 14, 2024 04:07PM
Immuneering to Participate in the Cowen 44th Annual Health Care Conference Mar 4, 2024 08:00AM
Immuneering Corporation (IMRX) Announces $30M Share Offering at $11/sh Apr 18, 2023 09:24AM
Immuneering Announces $30 Million Underwritten Offering Apr 18, 2023 09:24AM
Immuneering Announces $30 Million Underwritten Offering Apr 18, 2023 09:24AM


Feb 28, 2023 08:00AM Immuneering Announces Participation in March Investor Conferences
Feb 28, 2023 08:00AM Immuneering Announces Participation in March Investor Conferences
Feb 24, 2022 06:50AM Immuneering Announces Participation in March Investor Conferences
Aug 24, 2021 05:55AM UPDATE: Cowen Starts Immuneering Corporation (IMRX) at Outperform
Aug 3, 2021 04:07PM Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Aug 3, 2021 04:07PM Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Jul 30, 2021 11:28AM Immuneering Corp (IMRX) IPO Opens 30% Higher
Jul 30, 2021 05:26AM Immuneering Corporation (IMRX) Prices 7.5M Share IPO at $15/sh
Jul 29, 2021 10:47PM Immuneering Announces Pricing of Upsized Initial Public Offering
Jul 29, 2021 10:47PM Immuneering Announces Pricing of Upsized Initial Public Offering